Shares of PureTech Health plc (NASDAQ:PRTC – Get Rating) saw unusually-high trading volume on Wednesday . Approximately 968 shares traded hands during mid-day trading, a decline of 21% from the previous session’s volume of 1,227 shares.The stock last traded at $29.20 and had previously closed at $27.72.
Analyst Ratings Changes
Several research firms have issued reports on PRTC. Piper Sandler increased their target price on PureTech Health from $37.00 to $44.00 and gave the stock an “overweight” rating in a research report on Thursday, August 25th. SVB Leerink decreased their price target on shares of PureTech Health from $70.00 to $66.00 and set an “outperform” rating on the stock in a report on Wednesday, June 15th.
PureTech Health Trading Down 6.6 %
The firm’s fifty day moving average price is $27.67 and its two-hundred day moving average price is $25.06. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.54 and a quick ratio of 2.22.
Institutional Inflows and Outflows
PureTech Health Company Profile
PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and psychosis in Alzheimer's disease; a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions; an immunomodulation platform to treat chronic and acute inflammatory disorders; oral therapies based on defined consortia of bacteria is isolated from the human microbiome; and therapies to treat cognitive dysfunction associated with depression, multiple sclerosis, post COVID and ICU, and cancer related conditions.
- Get a free copy of the StockNews.com research report on PureTech Health (PRTC)
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.